Search Results - "Weissman, Peter N"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea by Weissman, Peter N., Carr, Molly C., Ye, June, Cirkel, Deborah T., Stewart, Murray, Perry, Caroline, Pratley, Richard

    Published in Diabetologia (01-12-2014)
    “…Aims/hypothesis The aim of this study was to compare the efficacy and safety of once-weekly albiglutide with once-daily insulin glargine (A21Gly,B31Arg,B32Arg…”
    Get full text
    Journal Article
  2. 2

    Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: long-term efficacy with or without rescue therapy by Home, Philip D, Ahrén, Bo, Reusch, Jane E.B, Rendell, Marc, Weissman, Peter N, Cirkel, Deborah T, Miller, Diane, Ambery, Philip, Carr, Molly C, Nauck, Michael A

    Published in Diabetes research and clinical practice (01-09-2017)
    “…Highlights • Efficacy results from five 3-year, phase 3 trials of the GLP-1RA albiglutide. • Less hyperglycaemic rescue needed with albiglutide vs placebo ( p…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients by Donaghue, Valerie M., Giurini, John M., Rosenblum, Barry I., Weissman, Peter N, Veves, Aristidis

    Published in Diabetes research and clinical practice (01-07-1995)
    “…We have examined the variability in function measurements of three sensory foot nerves in neuropathic diabetic patients and have compared them to measurements…”
    Get full text
    Journal Article
  5. 5

    Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study by Goldstein, Barry J., Weissman, Peter N., Wooddell, Margaret J., Waterhouse, Brian R., Cobitz, Alexander R.

    Published in Current medical research and opinion (01-09-2006)
    “…ABSTRACT Objective: To compare the effects of rosiglitazone added to metformin with dose escalation of metformin on cardiovascular risk biomarkers in type 2…”
    Get full text
    Journal Article
  6. 6

    Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus by Weissman, Peter N

    Published in The American journal of cardiology (05-09-2002)
    “…Nearly 16 million adults in the United States have diabetes mellitus, and the incidence of type 2 diabetes, the most prevalent form of diabetes, has steadily…”
    Get full text
    Journal Article Conference Proceeding
  7. 7
  8. 8